Cirtec Medical Board Announcement
Cirtec Medical, a renowned player in the world of design and manufacturing of intricate Class II and III medical devices, has made an exciting new addition to its Board of Directors. The company is thrilled to welcome Steven Chevillotte as a board member, effective immediately. His extensive experience and leadership capabilities make him a powerful asset as Cirtec Medical continues to innovate in the medical device sector.
Steven Chevillotte's Experience
Steven Chevillotte brings to Cirtec Medical over 20 years of international leadership experience, having made substantial contributions across the life sciences, aerospace, and advanced manufacturing sectors. His background is marked by his ability to drive growth within highly regulated environments, showcasing his expertise through operational excellence, mergers, acquisitions, and post-merger integration.
CEO of SaniSure
At present, he serves as the Chief Executive Officer of SaniSure, a leading name in the design and manufacture of single-use equipment for bioprocessing. Since taking charge in 2022, Steven has focused on enhancing global operations, fostering innovation through customer feedback, and broadening market strategies across the globe.
Proven Track Record
Before his role as CEO, Steven played a key role as Chief Financial Officer at SaniSure from June 2021 until June 2022. His journey also includes vital senior roles in finance and operations at Integrated Polymer Solutions and Consolidated Aerospace Manufacturing. His impact in those roles was transformative, leading revenue growth from $240 million to $400 million in a short span, culminating in a significant acquisition valued at $1.5 billion by Stanley Black & Decker.
A Legacy of Leadership
Steven's journey includes nearly a decade with ZEISS Surgical Ophthalmology, where he held increasingly senior positions. He was not only the Chief Financial Officer but also served as the Vice President of U.S. Operations and climbed to become the President of ZEISS North America, playing an indispensable role in enhancing the surgical platform for areas such as cataract, refractive, retina, and corneal surgery.
Statements from Leadership
Rich Relyea, Partner at 3i, lauded Steven's appointment by saying, "Steven has consistently demonstrated the kind of visionary leadership that drives real, measurable value. His ability to foster growth, drive efficiency, and develop high-performing teams is remarkable. I believe Steven's experience will significantly impact the Cirtec Medical board as the company embarks on its next phase of growth."
Shar Matin, the CEO of Cirtec Medical, expressed excitement about having Steven on board, remarking, "Steven's proven leadership in complex global environments, coupled with his technical depth and operational acumen, will provide valuable insights as we aim to scale our business and innovate for our customers."
Steven Chevillotte's Vision
Upon accepting his position, Steven expressed honor in joining Cirtec Medical's Board of Directors and looks forward to contributing towards the success of the company, emphasizing the importance of delivering long-term value for customers, employees, and stakeholders.
About Cirtec Medical
Cirtec Medical is a global leader in designing, developing, and manufacturing complex Class II and III medical devices. The company specializes in active implant systems, interventional devices, and high-precision components. Established in 1987, Cirtec Medical has built extensive in-house capabilities, allowing it to serve as a comprehensive partner to its customers, collaborating to transform innovative technologies into pioneering medical devices across a variety of therapeutic areas such as cardiology, neurology, and orthopedics. With its profound expertise in precision component design and manufacturing, Cirtec ensures quality and performance across every stage of the product lifecycle. The company operates 11 global facilities and has a vertically integrated model to streamline market entry, minimize risks, and boost revenue generation for its partners.
For Media Inquiries
For those interested in further information, contact: Abby Kupka, Sr. Manager of Marketing, Cirtec Medical at (763) 235-8835.
Frequently Asked Questions
Who is Steven Chevillotte?
Steven Chevillotte is a seasoned executive with over 20 years of leadership experience in sectors including life sciences and advanced manufacturing.
What does Cirtec Medical specialize in?
Cirtec Medical specializes in the design, development, and manufacturing of Class II and III medical devices, including active implant systems and interventional devices.
What role does Steven hold at SaniSure?
Steven is currently the Chief Executive Officer of SaniSure, leading initiatives for growth and innovation.
How long has Cirtec Medical been operational?
Cirtec Medical has been operating since 1987, providing extensive capabilities in medical device development.
What is the focus of Cirtec Medical's operations?
The focus includes providing innovative solutions in cardiology, neurology, orthopedics, and more, leveraging precision components.
